These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10147210)

  • 1. Successful antidote of multiple lethal infections using sustained delivery of difluoromethylornithine by means of ceramic drug delivery devices.
    Benghuzzi HA; England BG; Bajpai PK; Giffin BF
    Clin Mater; 1994; 15(3):151-60. PubMed ID: 10147210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained delivery of difluoromethylornithine (DFMO) by means of implantable ceramic devices.
    Benghuzzi HA; Bajpai PK
    J Invest Surg; 1988; 1(3):163-70. PubMed ID: 3154094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of azidothymidine (AZT) by ceramic drug delivery systems.
    Benghuzzi HA; Barbaro RM; Bajpai PK
    Biomed Sci Instrum; 1990; 26():151-6. PubMed ID: 2334759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of spermatogenesis by means of continuous delivery of danazol in combination with dihydrotestosterone from ALCAP drug delivery devices.
    Benghuzzi HA; Bajpai PK; England BG
    Biomed Sci Instrum; 1990; 26():141-9. PubMed ID: 2334758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of fibrous tissue formation surrounding intraperitoneal and subcutaneous implantation of ALCAP, HA, and TCP ceramic devices.
    Butler K; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 1997; 34():18-23. PubMed ID: 9603006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained delivery of aspirin by means of ALCAP ceramics.
    Snow KR; Muzina DJ; Bajpai PK
    Biomed Sci Instrum; 1989; 25():203-11. PubMed ID: 2742967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term delivery of testosterone by ALCAP ceramic implants in rats.
    Benghuzzi HA; Bajpai PK; England BG
    J Appl Biomater; 1990; 1(3):233-40. PubMed ID: 10171098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The delivery of testosterone and dihydrotestosterone by ALCAP ceramic implants in rats.
    Benghuzzi HA; Bajpai PK; England BG
    J Invest Surg; 1990; 3(3):197-215. PubMed ID: 2078543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric evaluation of tissue-implant reaction associated with ALCAP and TCP bioceramics in vivo.
    Butler KR; Benghuzzi HA; Puckett A
    J Invest Surg; 2001; 14(3):139-52. PubMed ID: 11453179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of hydrophilic compounds by resorbable and biodegradable ceramic drug delivery devices.
    Benghuzzi HA; England BG; Bajpai PK
    Biomed Sci Instrum; 1992; 28():179-82. PubMed ID: 1322731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term sustained delivery of 3'-azido-2',3'-dideoxythymidine in vivo by means of HA and TCP delivery devices.
    Benghuzzi H
    Biomed Sci Instrum; 2000; 36():343-8. PubMed ID: 10834256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of blood glucose by sustained delivery of insulin via ALCAP ceramics in rats.
    Muzina DJ; Snow KR; Bajpai PK
    Biomed Sci Instrum; 1989; 25():191-202. PubMed ID: 2663097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of the cellular components of the fibrous tissue matrix surrounding ALCAP, HA, and TCP bioceramics using adult male rats as a model.
    Butler K; Puckett A; Benghuzzi H
    Biomed Sci Instrum; 1999; 35():267-72. PubMed ID: 11143360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo delivery of estradiol from ceramic drug delivery devices.
    Benghuzzi HA; England BG; Bajpai PK
    Biomed Sci Instrum; 1991; 27():181-7. PubMed ID: 2065153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of HA, TCP and ALCAP bioceramic capsules on the viability of human monocyte and monocyte derived macrophages.
    Ross L; Benghuzzi H; Tucci M; Callender M; Cason Z; Spence L
    Biomed Sci Instrum; 1996; 32():71-9. PubMed ID: 8672693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained delivery of 3H-thymidine by means of ceramic capsules in rats.
    Benghuzzi HA; Barbaro RM; Bajpai PK
    Biomed Sci Instrum; 1989; 25():169-77. PubMed ID: 2742964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physiological response associated with large particles of TCP, HA, and ALCAP implants using raw 264.7 cells.
    Thorns M; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 2001; 37():287-92. PubMed ID: 11347404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ceramic drug delivery devices: the effect of various temperature of incubation on the delivery of biologicals.
    Benghuzzi HA; England BG; Bajpai PK
    Biomed Sci Instrum; 1992; 28():129-34. PubMed ID: 1643216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytological evaluation of the tissue-implant reaction associated with S/C and I/P implantation of ALCAP and HA bioceramics in vivo.
    Butler K; Benghuzzi H; Puckett A
    Pathol Res Pract; 2001; 197(1):29-39. PubMed ID: 11209814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics.
    Cannon MR; Bajpai PK
    Biomed Sci Instrum; 1995; 31():159-64. PubMed ID: 7654955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.